Nantahala Capital Management - CYMABAY THERAPEUTICS INC ownership

CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 102 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.4%.

Quarter-by-quarter ownership
Nantahala Capital Management ownership history of CYMABAY THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$6,058,712
-61.2%
553,307
-69.1%
0.59%
-51.0%
Q1 2023$15,609,698
+10.6%
1,790,103
-20.5%
1.20%
+30.7%
Q4 2022$14,111,005
+62.9%
2,250,559
-9.1%
0.92%
+63.4%
Q3 2022$8,661,000
+11.0%
2,474,659
-6.4%
0.56%
+43.2%
Q2 2022$7,801,000
+32.4%
2,644,306
+39.6%
0.39%
+49.8%
Q1 2022$5,890,000
-12.9%
1,893,997
-5.3%
0.26%
+9.7%
Q4 2021$6,760,0002,000,1420.24%
Other shareholders
CYMABAY THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,787,094$26,645,57214.80%
Lynx1 Capital Management LP 994,161$14,822,9419.80%
Octagon Capital Advisors LP 3,073,750$45,829,6137.04%
Saturn V Capital Management LP 1,124,459$16,765,6847.02%
Altium Capital Management LP 800,000$11,928,0006.22%
Affinity Asset Advisors, LLC 1,129,376$16,838,9964.74%
ACUTA CAPITAL PARTNERS, LLC 418,000$6,232,3804.18%
Cormorant Asset Management, LP 3,850,000$57,403,5003.35%
SILVERARC CAPITAL MANAGEMENT, LLC 590,000$8,796,9002.67%
MPM BioImpact LLC 610,770$9,106,5812.43%
View complete list of CYMABAY THERAPEUTICS INC shareholders